| Abstract: |
A composition and method for the use of Irvingia gabonensis seed extract for hunger suppression in obese individuals with low Leptin sensitivity, individuals with higher levels of ghrelin, and for individuals with Cannabis-induced appetite stimulation where dosage can be effectively administered in a gum base cold pressed into a tablet containing at least 100 mg of Irvingia gabonensis seed extract and Maltitol, Sorbitol, Isomalt, Xylitol, natural & artificial flavors, vegetarian magnesium stearate, Sucralose and Silicon dioxide. |
| Inventor: |
EPNER, PAUL (SAN DIEGO, CA, US); ZIMMER, III, RICHARD (MANDEVILLE, LA, US); MASSEY, BILL W. (HEBER SPRINGS, AR, US) |
| Applicant: |
ENGEN MEDICAL CORPORATION (San Diego, CA, US) |
| Face Assignee: |
N/A |
| Filed: |
2017-10-10 |
| Issued: |
2018-04-12 |
| Claims: |
7 |
|
US20180099016
|
1. A composition of Irvingia gabonensis seed extract comprising a dosage in an amount effective for hunger suppression in obese individuals with low Leptin sensitivity, individuals with higher levels of ghrelin and for individuals with Cannabis-induced appetite stimulation.
(1)
(0)
|
|
5. A method for hunger suppression in obese individuals with low Leptin sensitivity, individuals with higher levels of ghrelin, and for individuals with Cannabis-induced appetite stimulation comprising the administering of an effective amount of a composition of Irvingia gabonensis seed extract where the amount of Irvingia gabonensis seed extract is 100 mg.
(1)
(0)
|
|
